Redeye believes 2024 could better demonstrate Sedana Medical’s European expansion and increase the confidence in the US part of the equity story (NDA filing is approx. 12 months away). We believe quarterly sales, mainly coming from
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking.www.redeye.se/
© Modular Finance, source